92 related articles for article (PubMed ID: 20715761)
1. Creation and biophysical characterization of a high-affinity, monomeric EGF receptor ectodomain using fluorescent proteins.
Kozer N; Henderson C; Bailey MF; Rothacker J; Nice EC; Burgess AW; Clayton AH
Biochemistry; 2010 Sep; 49(35):7459-66. PubMed ID: 20715761
[TBL] [Abstract][Full Text] [Related]
2. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells.
Kozer N; Henderson C; Jackson JT; Nice EC; Burgess AW; Clayton AH
Phys Biol; 2011 Dec; 8(6):066002. PubMed ID: 21946082
[TBL] [Abstract][Full Text] [Related]
3. Dynamic conformational transitions of the EGF receptor in living mammalian cells determined by FRET and fluorescence lifetime imaging microscopy.
Ziomkiewicz I; Loman A; Klement R; Fritsch C; Klymchenko AS; Bunt G; Jovin TM; Arndt-Jovin DJ
Cytometry A; 2013 Sep; 83(9):794-805. PubMed ID: 23839800
[TBL] [Abstract][Full Text] [Related]
4. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
[TBL] [Abstract][Full Text] [Related]
5. Ligand binding induces a conformational change in epidermal growth factor receptor dimers.
Walker F; Rothacker J; Henderson C; Nice EC; Catimel B; Zhang HH; Scott AM; Bailey MF; Orchard SG; Adams TE; Liu Z; Garrett TP; Clayton AH; Burgess AW
Growth Factors; 2012 Dec; 30(6):394-409. PubMed ID: 23163584
[TBL] [Abstract][Full Text] [Related]
6. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
[TBL] [Abstract][Full Text] [Related]
7. Predominance of activated EGFR higher-order oligomers on the cell surface.
Clayton AH; Orchard SG; Nice EC; Posner RG; Burgess AW
Growth Factors; 2008 Dec; 26(6):316-24. PubMed ID: 18937111
[TBL] [Abstract][Full Text] [Related]
8. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.
Holbrook MR; Slakey LL; Gross DJ
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062
[TBL] [Abstract][Full Text] [Related]
10. Conformational dynamics in a truncated epidermal growth factor receptor ectodomain.
Kozer N; Rothacker J; Burgess AW; Nice EC; Clayton AH
Biochemistry; 2011 Jun; 50(23):5130-9. PubMed ID: 21591616
[TBL] [Abstract][Full Text] [Related]
11. Analysis of EGF receptor oligomerization by homo-FRET.
de Heus C; Kagie N; Heukers R; van Bergen en Henegouwen PM; Gerritsen HC
Methods Cell Biol; 2013; 117():305-21. PubMed ID: 24143984
[TBL] [Abstract][Full Text] [Related]
12. A FRET-based probe for epidermal growth factor receptor bound non-covalently to a pair of synthetic amphipathic helixes.
Itoh RE; Kurokawa K; Fujioka A; Sharma A; Mayer BJ; Matsuda M
Exp Cell Res; 2005 Jul; 307(1):142-52. PubMed ID: 15922734
[TBL] [Abstract][Full Text] [Related]
13. Single-molecule imaging of EGFR signalling on the surface of living cells.
Sako Y; Minoghchi S; Yanagida T
Nat Cell Biol; 2000 Mar; 2(3):168-72. PubMed ID: 10707088
[TBL] [Abstract][Full Text] [Related]
14. Unligated epidermal growth factor receptor forms higher order oligomers within microclusters on A431 cells that are sensitive to tyrosine kinase inhibitor binding.
Clayton AH; Tavarnesi ML; Johns TG
Biochemistry; 2007 Apr; 46(15):4589-97. PubMed ID: 17381163
[TBL] [Abstract][Full Text] [Related]
15. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
16. Structure-function studies of ligand-induced epidermal growth factor receptor dimerization.
Neelam B; Richter A; Chamberlin SG; Puddicombe SM; Wood L; Murray MB; Nandagopal K; Niyogi SK; Davies DE
Biochemistry; 1998 Apr; 37(14):4884-91. PubMed ID: 9538006
[TBL] [Abstract][Full Text] [Related]
17. Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots.
Kawashima N; Nakayama K; Itoh K; Itoh T; Ishikawa M; Biju V
Chemistry; 2010 Jan; 16(4):1186-92. PubMed ID: 20024999
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
Eberle A; Reinehr R; Becker S; Häussinger D
Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394
[TBL] [Abstract][Full Text] [Related]
19. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
20. Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: new insights from real-time single molecule analysis.
Yu C; Hale J; Ritchie K; Prasad NK; Irudayaraj J
Biochem Biophys Res Commun; 2009 Jan; 378(3):376-82. PubMed ID: 19014905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
